2015
DOI: 10.1111/tbj.12377
|View full text |Cite
|
Sign up to set email alerts
|

Myeloid Sarcoma of the Breast Misdiagnosed as Poorly Differentiated Mammary Carcinoma with Lobular Features

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
12
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(12 citation statements)
references
References 0 publications
0
12
0
Order By: Relevance
“…However, GS of the breast is often indistinguishable from benign tumors or lymphoma. For example, previous studies have reported patients presenting with an asymptomatic lump (5)(6)(7)(8), while other studies have reported patients presenting with a tender lump (9)(10)(11). Therefore, it is difficult to define typical features of affected patients.…”
Section: Introductionmentioning
confidence: 83%
“…However, GS of the breast is often indistinguishable from benign tumors or lymphoma. For example, previous studies have reported patients presenting with an asymptomatic lump (5)(6)(7)(8), while other studies have reported patients presenting with a tender lump (9)(10)(11). Therefore, it is difficult to define typical features of affected patients.…”
Section: Introductionmentioning
confidence: 83%
“…Of all breast leukemias, acute myelogenous leukemia is the most commonly occurring and it presents as myeloid sarcoma [11]. Myeloid sarcoma is an extramedullary hematological malignant tumor of myeloid cells showing varying degrees of maturation, and is most commonly observed in patients with previously diagnosed myeloid leukemia [3,12]. According to the World Health Organization, myeloid sarcomas can be classified into 3 categories: blastic (composed mainly of myeloblasts), immature (composed of myeloblast and promyelocytes), and differentiated (composed of promyelocytes and more mature neutrophils) [13].…”
Section: Discussionmentioning
confidence: 99%
“…The gold standard for the final diagnosis of myeloid sarcoma is histopathological examination combined with immunohistochemical testing [4]. Myeloperoxidase staining is often strongly positive in myeloid sarcoma [3].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Although MS is an extramedullary hematological malignancy, in which myeloid cells show various degrees of maturation, it is frequently seen in patients with previously diagnosed myeloid leukemia (9,10). According to the World Health Organization, MS is diagnosed based on three classes: blastic (consisting of myeloblasts), immature (consisting of myeloblasts and promyelocytes), and differentiated (consisting of promyelocytes and more mature neutrophils) (8).…”
Section: Discusson and Conclusionmentioning
confidence: 99%